Jenessa N. Johnston

Also affiliated with National Institute of Mental Health

NeuroscienceMedicinePsychology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “The impact of body mass index on the clinical features of bipolar disorder: A STEP‐BD study”.

The impact of body mass index on the clinical features of bipolar disorder: A STEP‐BD study

Bipolar Disorders(2023)10.1111/bdi.13370

N/A

0.518DataRank · unranked

11 citations

Zhi‐De Deng, Christoph Kraus, Jenessa N. Johnston, Adam Fijtman, Ioline D. Henter +3 more

κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine

Journal of Clinical Psychopharmacology(2023)10.1097/jcp.0000000000001663

N/A

0.284DataRank · unranked

4 citations

Gustavo C. Medeiros, Dede Greenstein, Peixiong Yuan, Jenessa N. Johnston, Lawrence T. Park +4 more

Response of iPSC-derived neurons from individuals with treatment-resistant depression to (2 R,6 R)-hydroxynorketamine and reelin: an exploratory study

Translational Psychiatry(2025)10.1038/s41398-025-03724-6

N/A

0.165DataRank · unranked

2 citations

Peixiong Yuan, Bashkim Kadriu, Nirmala Akula, Brandi Quintanilla, Shiyong Peng +9 more

Ketamine in neuropsychiatric disorders: an update

Neuropsychopharmacology(2023)10.1038/s41386-023-01632-1

N/A

0DataRank · unranked

99 citations

Bashkim Kadriu, Christoph Kraus, Ioline D. Henter, Carlos A. Zarate, Jenessa N. Johnston

Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment

Neuropharmacology(2023)10.1016/j.neuropharm.2023.109422

N/A

0DataRank · unranked

65 citations

Bashkim Kadriu, Josh Allen, Jessica R. Gilbert, Ioline D. Henter, Carlos A. Zarate +1 more

Positive AMPA receptor modulation in the treatment of neuropsychiatric disorders: A long and winding road

Drug Discovery Today(2021)10.1016/j.drudis.2021.07.027

N/A

0DataRank · unranked

58 citations

Laura Musazzi, Jenessa N. Johnston, Lisa E. Kalynchuk, Héctor J. Caruncho, Maurizio Popoli +2 more

Associations between hypothalamic-pituitary-adrenal (HPA) axis hormone levels, major depression features and antidepressant effects of ketamine

Journal of Affective Disorders(2024)10.1016/j.jad.2024.12.036

N/A

0DataRank · unranked

24 citations

Cristan Farmer, Gustavo C. Medeiros, Peixiong Yuan, Jenessa N. Johnston, Bashkim Kadriu +3 more

Esketamine in depression: putative biomarkers from clinical research

European Archives of Psychiatry and Clinical Neuroscience(2024)10.1007/s00406-024-01865-1

N/A

0DataRank · unranked

18 citations

Carlos A. Zarate, Mark D. Kvarta, Jenessa N. Johnston

Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile

Drug Discovery Today(2023)10.1016/j.drudis.2023.103518

N/A

0DataRank · unranked

64 citations

Maximillian Greenwald, Ioline D. Henter, Christoph Kraus, Anahit Mkrtchian, Neil G. Clark +5 more

Suicide Biomarkers to Predict Risk, Classify Diagnostic Subtypes, and Identify Novel Therapeutic Targets: 5 Years of Promising Research

The International Journal of Neuropsychopharmacology(2021)10.1093/ijnp/pyab083

N/A

0DataRank · unranked

53 citations

Darcy Campbell, Héctor J. Caruncho, Ioline D. Henter, Elizabeth D. Ballard, Carlos A. Zarate +1 more

The antidepressant actions of ketamine and its enantiomers

Pharmacology & Therapeutics(2023)10.1016/j.pharmthera.2023.108431

N/A

0DataRank · unranked

106 citations

Ioline D. Henter, Carlos A. Zarate, Jenessa N. Johnston